Covaris launched two virus RNA extraction kits for nasopharyngeal swab sample collection equipment

Covaris, Inc announced Tuesday that it has launched two new viral RNA extraction kits for nasopharyngeal swab sample collection devices The first new product is a truxtrac virus RNA extraction kit using Puritan swabs, which contains all components for downstream analysis using synthetic swabs for high-quality RNA extraction and magnetic bead purification The second new product is the truxtrac-pcr direct virus RNA extraction kit, which can be directly used in real-time RT-PCR (reverse transcription polymerase chain reaction) detection without prior purification, and also contains internal control Covaris is now working with a Chinese customer to assess the effectiveness of these new active extraction kits for covid-19 virus detection In terms of controlling potential outbreaks, accurate diagnosis is essential for authorities to conduct epidemiological studies in order to determine the basis for the best course of action The unsuccessful quality control (QC) process or false negative results of COVID-19 virus do not necessarily indicate that the analysis technique is not accurate Advanced analysis can not make up for the bad consequences of low sample extraction level and inadequate preparation For example, real-time RT-PCR for rapid detection and / or high-throughput sequencing for macro genomic research require effective pre analysis sample preparation Jim laugharn, covaris founder and CEO, commented: "when dealing with difficult to input biological samples, such as swab samples, robust and efficient sample preparation is the key to reduce false negative results Our goal is to use active acoustic processing to standardize and simplify the workflow " Covaris adaptive Focused Acoustics